Thomas Pap

851 total citations
7 papers, 689 citations indexed

About

Thomas Pap is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Thomas Pap has authored 7 papers receiving a total of 689 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Rheumatology, 3 papers in Immunology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Thomas Pap's work include Rheumatoid Arthritis Research and Therapies (3 papers), Toxin Mechanisms and Immunotoxins (2 papers) and Virus-based gene therapy research (2 papers). Thomas Pap is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (3 papers), Toxin Mechanisms and Immunotoxins (2 papers) and Virus-based gene therapy research (2 papers). Thomas Pap collaborates with scholars based in Switzerland, Germany and Italy. Thomas Pap's co-authors include Steffen Gay, Renate E. Gay, Karlfried R. Aupperle, Gary S. Firestein, Otylia Kowal‐Bielecka, Oliver Distler, Ulf M�ller-Ladner, Serena Guiducci, J�rgen Sch�lmerich and Michael Landthaler and has published in prestigious journals such as Arthritis & Rheumatism and Arthritis Research.

In The Last Decade

Thomas Pap

7 papers receiving 674 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Pap Switzerland 6 246 238 191 144 137 7 689
Chul-Soo Cho South Korea 14 278 1.1× 193 0.8× 292 1.5× 142 1.0× 171 1.2× 15 816
Justyna Chwiećko Poland 13 98 0.4× 287 1.2× 125 0.7× 93 0.6× 63 0.5× 27 533
Ágnes Szentpétery Ireland 14 199 0.8× 410 1.7× 380 2.0× 85 0.6× 55 0.4× 31 785
Christina Wunrau Germany 6 339 1.4× 339 1.4× 188 1.0× 161 1.1× 29 0.2× 12 777
Anette Knedla Germany 4 244 1.0× 305 1.3× 162 0.8× 140 1.0× 27 0.2× 5 650
Ingmar Meinecke Germany 9 311 1.3× 276 1.2× 110 0.6× 123 0.9× 25 0.2× 22 737
D L Boyle United States 11 154 0.6× 376 1.6× 234 1.2× 152 1.1× 65 0.5× 11 713
Fumihiro Kimura Japan 12 271 1.1× 117 0.5× 92 0.5× 84 0.6× 30 0.2× 39 628
N. Vandeghinste Belgium 9 182 0.7× 139 0.6× 154 0.8× 170 1.2× 44 0.3× 15 586
Lynett Danks United Kingdom 9 278 1.1× 130 0.5× 352 1.8× 166 1.2× 38 0.3× 9 710

Countries citing papers authored by Thomas Pap

Since Specialization
Citations

This map shows the geographic impact of Thomas Pap's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Pap with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Pap more than expected).

Fields of papers citing papers by Thomas Pap

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Pap. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Pap. The network helps show where Thomas Pap may publish in the future.

Co-authorship network of co-authors of Thomas Pap

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Pap. A scholar is included among the top collaborators of Thomas Pap based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Pap. Thomas Pap is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Distler, Oliver, Thomas Pap, Otylia Kowal‐Bielecka, et al.. (2001). Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: Role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis. Arthritis & Rheumatism. 44(11). 2665–2678. 128 indexed citations
2.
Pap, Thomas, Karlfried R. Aupperle, Steffen Gay, Gary S. Firestein, & Renate E. Gay. (2001). Invasiveness of synovial fibroblasts is regulated by p53 in the SCID mouse in vivo model of cartilage invasion. Arthritis & Rheumatism. 44(3). 676–681. 90 indexed citations
3.
Pap, G., A. Machner, Renate E. Gay, et al.. (2001). Development and characteristics of a synovial-like interface membrane around cemented tibial hemiarthroplasties in a novel rat model of aseptic prosthesis loosening. Arthritis & Rheumatism. 44(4). 956–963. 35 indexed citations
4.
Kowal‐Bielecka, Otylia, Oliver Distler, Michel Neidhart, et al.. (2001). Evidence of 5-lipoxygenase overexpression in the skin of patients with systemic sclerosis: A newly identified pathway to skin inflammation in systemic sclerosis. Arthritis & Rheumatism. 44(8). 1865–1875. 31 indexed citations
5.
Pap, Thomas, et al.. (2000). Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis.. Arthritis Research. 2(5). 361–361. 388 indexed citations
6.
Gay, Steffen, Thomas Pap, Michael Nawrath, Juliane K. Franz, & Renate E. Gay. (2000). Activation of Synovial Fibroblasts in Rheumatoid Arthritis. Arthritis Research. 1(Suppl 1). S19–S19. 1 indexed citations
7.
Pap, Thomas, Ulf Müller‐Ladner, Renate Gay, & Steffen Gay. (1999). Gene therapy in rheumatoid arthritis: how to target joint destruction?. Arthritis Research. 1(1). 5–5. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026